Laboratory record
Intertek Pharmaceutical Services
A technically detailed, peptide-dedicated characterisation service: reversed-phase, normal-phase and HILIC chromatography, primary sequence confirmation by LC-MS/MS peptide mapping, and peptide-related impurity profiling by UPLC/HPLC high-resolution MS/MS. Aimed at pharmaceutical development rather than single-vial verification.
Manchester, England, United Kingdom
Published capabilities
Recorded from the laboratory’s own live pages. “Not stated” means the laboratory has not published a position — it is not a statement that the service is unavailable.
- Peptide-specific testing
- Yes
- HPLC
- Yes
- LC-MS
- Yes
- Mass spectrometry
- Yes
- Identity
- Yes
- Purity
- Yes
- Amino acid analysis
- Not stated
- Endotoxin
- Not stated
- Sterility
- Not stated
Accreditation and working terms
- Accreditation
- Self-reported: “Laboratories that are GLP/GCP and cGMP inspected by regulatory authorities, providing services aligned with global regulatory frameworks (FDA, EMA, ICH, OECD GLP, GMP).” Regulatory inspection status, not accreditation.Self-reported
- Turnaround time
- Not publicly stated
- Sample requirements
- Not publicly stated
- Report policy
- Not publicly stated — contract research model, reports to the client.
Sources
- Intertek — peptide analysis and formulationMethods and inspection claims read from the live page on 3 September 2026.
Last reviewed 3 September 2026 · Report an inaccuracy in this record